These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


139 related items for PubMed ID: 21153134

  • 1. Immunoreactive prolactins of the neurohypophyseal system display actions characteristic of prolactin and 16K prolactin.
    López-Gómez FJ, Torner L, Mejía S, de la Escalera GM, Clapp C.
    Endocrine; 1995 Aug; 3(8):573-8. PubMed ID: 21153134
    [Abstract] [Full Text] [Related]

  • 2. The prolactin gene is expressed in the hypothalamic-neurohypophyseal system and the protein is processed into a 14-kDa fragment with activity like 16-kDa prolactin.
    Clapp C, Torner L, Gutiérrez-Ospina G, Alcántara E, López-Gómez FJ, Nagano M, Kelly PA, Mejía S, Morales MA, Martínez de la Escalera G.
    Proc Natl Acad Sci U S A; 1994 Oct 25; 91(22):10384-8. PubMed ID: 7937959
    [Abstract] [Full Text] [Related]

  • 3. Proteolysis of human prolactin: resistance to cathepsin D and formation of a nonangiostatic, C-terminal 16K fragment by thrombin.
    Khurana S, Liby K, Buckley AR, Ben-Jonathan N.
    Endocrinology; 1999 Sep 25; 140(9):4127-32. PubMed ID: 10465285
    [Abstract] [Full Text] [Related]

  • 4. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras-Tiam1-Rac1-Pak1 signaling pathway.
    Lee SH, Kunz J, Lin SH, Yu-Lee LY.
    Cancer Res; 2007 Nov 15; 67(22):11045-53. PubMed ID: 18006851
    [Abstract] [Full Text] [Related]

  • 5. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation.
    Gonzalez C, Corbacho AM, Eiserich JP, Garcia C, Lopez-Barrera F, Morales-Tlalpan V, Barajas-Espinosa A, Diaz-Muñoz M, Rubio R, Lin SH, Martinez de la Escalera G, Clapp C.
    Endocrinology; 2004 Dec 15; 145(12):5714-22. PubMed ID: 15358675
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The 16-kilodalton N-terminal fragment of human prolactin is a potent inhibitor of angiogenesis.
    Clapp C, Martial JA, Guzman RC, Rentier-Delure F, Weiner RI.
    Endocrinology; 1993 Sep 15; 133(3):1292-9. PubMed ID: 7689950
    [Abstract] [Full Text] [Related]

  • 11. Prolactins are natural inhibitors of angiogenesis in the retina.
    Aranda J, Rivera JC, Jeziorski MC, Riesgo-Escovar J, Nava G, López-Barrera F, Quiróz-Mercado H, Berger P, Martínez de la Escalera G, Clapp C.
    Invest Ophthalmol Vis Sci; 2005 Aug 15; 46(8):2947-53. PubMed ID: 16043870
    [Abstract] [Full Text] [Related]

  • 12. A specific, high affinity, saturable binding site for the 16-kilodalton fragment of prolactin on capillary endothelial cells.
    Clapp C, Weiner RI.
    Endocrinology; 1992 Mar 15; 130(3):1380-6. PubMed ID: 1311239
    [Abstract] [Full Text] [Related]

  • 13. Biological and immunological characterization of cleaved and 16K forms of rat prolactin.
    Clapp C, Sears PS, Russell DH, Richards J, Levay-Young BK, Nicoll CS.
    Endocrinology; 1988 Jun 15; 122(6):2892-8. PubMed ID: 3371265
    [Abstract] [Full Text] [Related]

  • 14. Binding studies with intact rat prolactin and a 16K fragment of the hormone.
    Clapp C, Sears PS, Nicoll CS.
    Endocrinology; 1989 Aug 15; 125(2):1054-9. PubMed ID: 2752964
    [Abstract] [Full Text] [Related]

  • 15. Inhibition of urokinase activity by the antiangiogenic factor 16K prolactin: activation of plasminogen activator inhibitor 1 expression.
    Lee H, Struman I, Clapp C, Martial J, Weiner RI.
    Endocrinology; 1998 Sep 15; 139(9):3696-703. PubMed ID: 9724020
    [Abstract] [Full Text] [Related]

  • 16. Hypoxia inhibits expression of prolactin and secretion of cathepsin-D by the GH4C1 pituitary adenoma cell line.
    Cosío G, Jeziorski MC, López-Barrera F, De La Escalera GM, Clapp C.
    Lab Invest; 2003 Nov 15; 83(11):1627-36. PubMed ID: 14615416
    [Abstract] [Full Text] [Related]

  • 17. Proteolytic cleavage confers nitric oxide synthase inducing activity upon prolactin.
    Corbacho AM, Nava G, Eiserich JP, Noris G, Macotela Y, Struman I, Martinez De La Escalera G, Freeman BA, Clapp C.
    J Biol Chem; 2000 May 05; 275(18):13183-6. PubMed ID: 10788422
    [Abstract] [Full Text] [Related]

  • 18. 16K prolactin induces NF-kappaB activation in pulmonary fibroblasts.
    Macotela Y, Mendoza C, Corbacho AM, Cosío G, Eiserich JP, Zentella A, Martínez de la Escalera G, Clapp C.
    J Endocrinol; 2002 Dec 05; 175(3):R13-8. PubMed ID: 12475392
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.